Literature DB >> 18070696

The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer.

R Lambert1, P Hainaut.   

Abstract

Oesophagogastric cancer occurs in the oesophagus, the oesophagogastric region and the stomach, including the proximal and distal stomach. In 2005, the worldwide burden of oesophagogastric cancer was estimated to be 1,500,000 new cases (500,000 oesophagus and 1,000,000 stomach). Squamous cell cancer is linked with alcohol and tobacco consumption in Western countries. Its incidence is much higher in regions of Asia with a low-socio-economic status, nutritional deficiencies, poor oral status, carcinogens absorbed with smoked meat, fat-cooked foodstuffs, vegetables containing toxic alkaloids or mycotoxins, and water containing nitrites, nitrates and nitrosamines. Adenocarcinoma develops in the columnar lined oesophagus. Its incidence is still low but there is an increasing trend. The incidence of stomach cancer is decreasing worldwide, but is still high in Japan. Causal factors include Helicobacter pylori infection with atrophic gastritis and a diet poor in fruit and vegetables. Preneoplastic conditions of the oesophagogastric mucosa include erosive oesophagitis in alcoholics, columnar lined oesophagus as a complication of gastro-oesophageal reflux disease, and atrophic gastritis following H. pylori infection.

Entities:  

Mesh:

Year:  2007        PMID: 18070696     DOI: 10.1016/j.bpg.2007.10.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  63 in total

1.  The status of phosphorylated p38 in esophageal squamous cell carcinoma.

Authors:  Shu-Tao Zheng; Chuan-Shan Zhang; Xu Qin; Yue-Hua Gen; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.

Authors:  Ayshamgul Hasim; Hong Ma; Batur Mamtimin; Abulizi Abudula; Madiniyet Niyaz; Li-Wei Zhang; Juret Anwer; Ilyar Sheyhidin
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

3.  Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang.

Authors:  Zan Liu; Jun-Guo Feng; Aerziguli Tuersun; Tao Liu; Hui Liu; Qing Liu; Shu-Tao Zheng; Cong-Gai Huang; Guo-Dong Lv; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2010-12-02       Impact factor: 2.316

4.  MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.

Authors:  Laura A Kresty; Jennifer Clarke; Kristin Ezell; Amy Exum; Amy B Howell; Toumy Guettouche
Journal:  J Carcinog       Date:  2011-12-22

5.  MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.

Authors:  Fengxia Liu; Shutao Zheng; Tao Liu; Qing Liu; Meng Liang; Xiuling Li; Ilyar Sheyhidin; Xiaomei Lu; Wenya Liu
Journal:  Mol Cell Biochem       Date:  2013-05-25       Impact factor: 3.396

6.  Early Oral Feeding After Surgery for Upper Gastrointestinal Malignancies: A Prospective Cohort Study.

Authors:  Saeed Shoar; Mohammad Naderan; Habibollah Mahmoodzadeh; Negin Hosseini-Araghi; Nastaran Mahboobi; Freydoon Sirati; Zhamak Khorgami
Journal:  Oman Med J       Date:  2016-05

7.  Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.

Authors:  Hong Ma; Ayshamgul Hasim; Batur Mamtimin; Bin Kong; Hai-Ping Zhang; Ilyar Sheyhidin
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

8.  Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.

Authors:  Linwei Li; Wenyu Wang; Xiaoyan Li; Tianhui Gao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

9.  Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer.

Authors:  Tian-Jie Qin; Gai-Li An; Xin-Han Zhao; Fang Tian; Xiao-Hua Li; Juan-Wen Lian; Bo-Rong Pan; Shan-Zhi Gu
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

10.  Gastric hyposecretion in esophageal squamous-cell carcinomas.

Authors:  K Iijima; T Koike; Y Abe; H Yamagishi; N Ara; K Asanuma; K Uno; A Imatani; N Nakaya; S Ohara; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.